Patents by Inventor Xavier Loyer

Xavier Loyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9193971
    Abstract: The present invention relates to the treatment of nonalcoholic steatohepatitis (NASH), in particular to a compound that inhibits miR-21 expression for use in the treatment of nonalcoholic steatohepatitis.
    Type: Grant
    Filed: April 10, 2013
    Date of Patent: November 24, 2015
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Universite Paris Descartes
    Inventors: Alain Tedgui, Xavier Loyer, Pierre-Emmanuel Rautou
  • Publication number: 20150297628
    Abstract: The present invention relates to the treatment and the diagnosis of atherosclerosis, in particular to a miRNA for use in the treatment and the diagnosis of atherosclerosis.
    Type: Application
    Filed: June 25, 2015
    Publication date: October 22, 2015
    Inventors: Alain TEDGUI, Xavier LOYER, Jean MACCARIO
  • Publication number: 20150057332
    Abstract: The present invention relates to the treatment of nonalcoholic steatohepatitis (NASH), in particular to a compound that inhibits miR-21 expression for use in the treatment of nonalcoholic steatohepatitis.
    Type: Application
    Filed: April 10, 2013
    Publication date: February 26, 2015
    Inventors: Alain Tedgui, Xavier Loyer, Pierre-Emmanuel Rautou
  • Publication number: 20140288156
    Abstract: The present invention relates to the treatment and the diagnosis of atherosclerosis, in particular to a miRNA for use in the treatment and the diagnosis of atherosclerosis.
    Type: Application
    Filed: October 29, 2012
    Publication date: September 25, 2014
    Inventors: Alain Tedgui, Xavier Loyer, Jean MacCario